Research demonstrates a refined sterility testing method using ATP bioluminescence in biological products, suggesting improved reliability.
Rapid methods have secured a foothold within the pharmaceutical industry. However, we continue to evolve our technologies to meet the increasing demand of modern medicines. One of the drawbacks for using metabolic by-products as an indicator of microorganism growth is the risk of poor differentiation between biological signals from the product and microbial metabolites.A new assay was designed to deal with a higher background signal. By utilizing a biochemical ATP-depletion reagent, coupled with utilizing microbial adenylate kinase to enhance ATP production, a more refined, flexible assay is available for rapid sterility testing. I present evidence demonstrating the reliability of modern ATP bioluminescence assays for testing biological products. Data graphs will include: Diagram of ATP depletion/AK-ATP enhancement at the cellular level.Case studies of Applicability of an ATP-depletion reagent User eliminates the need for low-ATP sterility media (use any media supplier you want)Reduction of residual signal from a biologically derived product.3-way Equivalence/LOD data amongst 1) Compendial Sterility 2) ATP Bioluminescence 3) ATP Bioluminescence with background depletion.
No takes yet. Share an insight, caveat, or question.
Stacey Ramsey (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: